Canopy Growth Q4 Loss Narrows

Canopy Growth Corp. (CGC, WEED.TO) reported that its fourth-quarter net loss attributable to the company was C$574.62 million or C$1.46 per share, sharply narrower than C$699.98 million or C$1.85 per share in the prior-year quarter.

On average, eight analysts polled by Thomson Reuters expected the company to report a loss of C$0.31 per share for the quarter. Analysts' estimates typically exclude special items.

Net revenue for the quarter declined 25 percent to C$111.77 million from C$148.44 million in the same quarter last year. Analysts expected revenues of C$129.00 million for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Communications Commission or FCC has granted SpaceX Services, Inc. authorization to use its Starlink satellite internet system on vehicles in motion. SpaceX, owned by Elon Musk, is allowed to operate consumer and enterprise Ku-band Earth Stations in Motion or ESIM using frequencies allocated to the fixed satellite service. The approval would help the company to expand its services to Loud Muscle Science, LLC is recalling certain Launch Sequence products in the United States and Canada citing the presence of undeclared Tadalafil, the U.S. Food and Drug Administration said. These tainted Launch Sequence Capsule products are marketed as dietary supplements for male sexual enhancement. The U.S. Food and Drug Administration announced the intended availability of around 17 million bottles equivalent of general infant formula to be imported from New Zealand and Ireland. Under the FDA's enforcement discretion to source more infant formula to the U.S., French food company Danone SA will send 555,000 cans Aptamil Gold Plus from New Zealand.
Follow RTT